Nexien BioPharmaNXEN 
$0.0217.65%24h
17.65%24h
Global rank36552
Market cap$1.25M
Change 7d17.65%
YTD Performance-44.44%
SP500 benchmarkUnderperform
P/E-2.00
P/S0
Revenue$0
Earnings-$361.90K
Dividend yield-
Main Sector
Healthcare
Nexien BioPharma (NXEN) Stock Overview
Nexien BioPharma, Inc. focuses on the formulation, development, and commercialization of cannabinoid-based pharmaceuticals, drug delivery systems, and related technologies for diseases, disorders, and medical conditions. The company was formerly known as Intiva BioPharma Inc. and changed its name to Nexien BioPharma, Inc. in September 2018. Nexien BioPharma, Inc. is based in Glendale, Colorado.
NXEN Stock Information
Symbol
NXENAddress
4340 East Kentucky AvenueGlendale, CO 80246United States
Founded
-Trading hours
-Website
https://www.nexienbiopharma.comCountry
🇺🇸 United StatesPhone Number
303 495 7583Nexien BioPharma (NXEN) Price Chart
-
Value:-
Nexien BioPharma Overview: Key Details and Summary
Stock data | 2023 | Change |
|---|---|---|
| Price | $0.02 | N/A |
| Market Cap | $1.25M | N/A |
| Shares Outstanding | 62.33M | 7.73% |
| Employees | 0 | N/A |
| Shareholder Equity | -252.01K | 114.28% |
Valuation | 2023 | Change |
|---|---|---|
| P/E Ratio | -2.00 | N/A |
| P/B Ratio | -4.95 | N/A |
Growth | 2023 | Change |
|---|---|---|
| Return on Equity | 1.4361 | N/A |
Earnings | 2023 | Change |
|---|---|---|
| Revenue | $0 | N/A |
| Earnings | -$361.90K | N/A |
| EPS | -0.01 | N/A |
| Earnings Yield | -0.5 | N/A |
Financial Strength | 2023 | Change |
|---|---|---|
| Total Assets | $43.13K | N/A |
| Cash on Hand | $35.15K | N/A |
| Debt to Equity | -1.1711 | -43.12% |
| Current Ratio | 0.1461 | -71.59% |
